LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 16.85 | 17.25 | 1382 | 655 | 2.1081 | 1.3054 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 16.85 | 17.25 | 355 | 655 | 0.5415 | 0.7794 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 16.85 | 17.25 | 1517 | 655 | 2.3140 | 1.3467 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 18.82 | 17.25 | 1 | 800 | 0.0012 | -0.4022 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 18.82 | 17.25 | 1539 | 800 | 1.9225 | 1.2506 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 18.82 | 17.25 | 630 | 800 | 0.7870 | 0.9153 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 18.82 | 17.25 | 1678 | 800 | 2.0962 | 1.2861 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 20.79 | 17.25 | 1 | 1001 | 0.0010 | -0.3849 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 20.79 | 17.25 | 1636 | 1001 | 1.6333 | 1.1747 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 20.79 | 17.25 | 1199 | 1001 | 1.1970 | 1.0623 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 20.79 | 17.25 | 1826 | 1001 | 1.8230 | 1.2158 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 22.76 | 17.25 | 1 | 1193 | 0.0008 | -0.3725 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 22.76 | 17.25 | 1719 | 1193 | 1.4402 | 1.1230 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 22.76 | 17.25 | 1549 | 1193 | 1.2978 | 1.0871 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 22.76 | 17.25 | 1921 | 1193 | 1.6095 | 1.1619 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 24.73 | 17.25 | 1 | 1290 | 0.0008 | -0.3672 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 24.73 | 17.25 | 1761 | 1290 | 1.3649 | 1.1025 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 24.73 | 17.25 | 1797 | 1290 | 1.3928 | 1.1093 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 24.73 | 17.25 | 2019 | 1290 | 1.5649 | 1.1492 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 26.70 | 17.25 | 1 | 1466 | 0.0007 | -0.3587 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 26.70 | 17.25 | 1930 | 1466 | 1.3159 | 1.0875 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 26.70 | 17.25 | 1973 | 1466 | 1.3452 | 1.0947 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 26.70 | 17.25 | 2149 | 1466 | 1.4652 | 1.1228 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 28.67 | 17.25 | 1 | 1653 | 0.0006 | -0.3512 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 28.67 | 17.25 | 2055 | 1653 | 1.2431 | 1.0672 | MN20160310_N02 | K14 |